Lista de obras - Hyo Song Kim - Dominio Público Uruguay

A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy

artículo científico publicado en 2018

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma

artículo científico publicado en 2016

A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis

artículo científico publicado en 2011

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

artículo científico publicado en 2012

Advanced Detection of Recent Changing Trends in Gastric Cancer Survival: Up-to-date Comparison by Period Analysis ⬇️

artículo científico publicado el 1 de diciembre de 2011

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer

artículo científico publicado en 2017

Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

artículo científico publicado en 2010

Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.

artículo científico publicado en 2014

Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer

artículo científico publicado en 2017

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.

scientific article published on 16 June 2016

Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.

artículo científico publicado en 2016

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab

artículo científico publicado en 2017

Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma

artículo científico publicado en 2018

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

artículo científico publicado en 2008

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.

artículo científico publicado en 2013

Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial

artículo científico publicado en 2018

Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children

artículo científico publicado en 2014

Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer

artículo científico publicado en 2017

Leiomyosarcoma: investigation of prognostic factors for risk-stratification model

article

Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial

scientific article published on 26 July 2018

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy

artículo científico publicado en 2018

Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

artículo científico publicado en 2010

PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.

artículo científico publicado en 2015

Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea.

artículo científico publicado en 2017

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients.

artículo científico publicado en 2013

Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer

scientific article published on 11 July 2019

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience

artículo científico publicado en 2016

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.

artículo científico publicado en 2016

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma

artículo científico publicado en 2016

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.

artículo científico publicado en 2018

Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.

artículo científico publicado en 2016

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma

artículo científico publicado en 2016

Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.

artículo científico publicado en 2014

Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial

artículo científico publicado en 2018

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm

artículo científico publicado en 2016

Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration

artículo científico publicado en 2016

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.

artículo científico publicado en 2015

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial

artículo científico publicado en 2018

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.

artículo científico publicado en 2011

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

artículo científico publicado en 2011

The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.

artículo científico

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.

artículo científico

The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.

artículo científico publicado en 2017

Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.

artículo científico publicado en 2013

Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea

artículo científico publicado en 2009

Vascular soft-tissue sarcomas: a prognostic model from a retrospective single-center study.

artículo científico publicado en 2014

Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis.

artículo científico publicado en 2012

Lista de obras de Hyo Song Kim

A Prediction Model of Tumor Progression and Survival in HER2-Positive Metastatic Gastric Cancer Patients Treated with Trastuzumab and Chemotherapy

A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma

A prognostic model to predict clinical outcome in gastric cancer patients with bone metastasis

A randomized phase II trial of S-1-oxaliplatin versus capecitabine-oxaliplatin in advanced gastric cancer.

Advanced Detection of Recent Changing Trends in Gastric Cancer Survival: Up-to-date Comparison by Period Analysis ⬇️

Cardiotoxicity of trastuzumab in patients with HER2-positive gastric cancer

Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

Clinicopathological features and prognostic significance of HER2 expression in gastric cancer.

Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer

Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: implications for individualized therapy.

Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy.

Depth of response is a significant predictor for long-term outcome in advanced gastric cancer patients treated with trastuzumab

Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma

ERCC1 expression as a predictive marker of squamous cell carcinoma of the head and neck treated with cisplatin-based concurrent chemoradiation

Efficacy and safety of everolimus in Korean patients with metastatic renal cell carcinoma.

Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial

Incidence and Survival of Pediatric Soft Tissue Sarcomas: Comparison between Adults and Children

Integration of radiotherapy and chemotherapy for abdominal lymph node recurrence in gastric cancer

Leiomyosarcoma: investigation of prognostic factors for risk-stratification model

Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial

Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy

Noncutaneous malignant melanoma: a prognostic model from a retrospective multicenter study

PTEN deficiency as a predictive biomarker of resistance to HER2-targeted therapy in advanced gastric cancer.

Patterns of Care for Radiotherapy in the Neoadjuvant and Adjuvant Treatment of Gastric Cancer: A Twelve-Year Nationwide Cohort Study in Korea.

Pharmacogenetic determinants associated with sunitinib-induced toxicity and ethnic difference in Korean metastatic renal cell carcinoma patients.

Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.

Prognostic implications of PIK3CA amplification in curatively resected liposarcoma

Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.

Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer.

Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma

Proper timing of adjuvant chemotherapy affects survival in patients with stage 2 and 3 gastric cancer.

Real-Time Tumor Gene Expression Profiling to Direct Gastric Cancer Chemotherapy: Proof-of-Concept "3G" Trial

Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm

Recursive partition analysis of peritoneal and systemic recurrence in patients with gastric cancer who underwent D2 gastrectomy: Implications for neoadjuvant therapy consideration

Results of a Phase II Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Patients Who Failed First-Line Therapy Containing Dacarbazine.

S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer.

Sunitinib for Asian patients with advanced renal cell carcinoma: a comparable efficacy with different toxicity profiles.

The clinical outcome of chemotherapy-induced amenorrhea in premenopausal young patients with breast cancer with long-term follow-up.

The frequency and impact of FGFR1 amplification on clinical outcomes in Korean patients with small cell lung cancer.

The prognostic value of volume-based parameters using 18F-FDG PET/CT in gastric cancer according to HER2 status.

Therapeutic strategies for well-differentiated papillary mesothelioma of the peritoneum.

Treatment outcomes of sunitinib treatment in advanced renal cell carcinoma patients: a single cancer center experience in Korea

Vascular soft-tissue sarcomas: a prognostic model from a retrospective single-center study.

Weekly gemcitabine and docetaxel in refractory soft tissue sarcoma: a retrospective analysis.